• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者化疗引起的不良反应与健康相关生活质量之间的关系

Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer.

作者信息

Prieto-Callejero Blanca, Rivera Francisco, Fagundo-Rivera Javier, Romero Adolfo, Romero-Martín Macarena, Gómez-Salgado Juan, Ruiz-Frutos Carlos

机构信息

Hospital Virgen de la Bella, Lepe, Huelva.

Department of Experimental Psychology, Faculty of Psychology, University of Seville, Seville.

出版信息

Medicine (Baltimore). 2020 Aug 14;99(33):e21695. doi: 10.1097/MD.0000000000021695.

DOI:10.1097/MD.0000000000021695
PMID:32872042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7437745/
Abstract

BACKGROUND AND OBJECTIVES

Chemotherapy does not only affect cancer cells; it also affects, to a greater or lesser degree, all other cells in the body. This toxicity should be assessed according to its severity, frequency, and duration, taking into account objective and subjective dimensions in its assessment. This assessment is a highly relevant aspect when providing care to chemotherapy patients, mainly due to the impact of the treatment on the patient's quality of life, as well as the vital risk it may imply under certain circumstances. For all this, the objective of this study was to assess the relationship between chemotherapy-associated adverse reactions and health-related quality of life in breast cancer patients.

MATERIALS AND METHODS

With this purpose, a descriptive cross-sectional study was developed on 110 breast cancer patients who were treated with docetaxel, epirubicin, and cyclophosphamide.

RESULTS

It is worth highlighting the negative effect of nausea, dysgeusia, peripheral neuropathy, loss of appetite, myalgia, and peripheral edema on the quality of life. Likewise, it is worth mentioning peripheral neuropathy as the toxicity that affects a greater number of quality-of-life indicators.

CONCLUSIONS

To sum up, it would be necessary to make health professionals aware of the importance of chemotherapy-associated adverse reactions.

摘要

背景与目的

化疗不仅会影响癌细胞;它还会或多或少地影响体内所有其他细胞。这种毒性应根据其严重程度、发生频率和持续时间进行评估,评估时要考虑客观和主观方面。在为化疗患者提供护理时,这种评估是一个高度相关的方面,主要是因为治疗对患者生活质量的影响,以及在某些情况下可能意味着的生命风险。综上所述,本研究的目的是评估乳腺癌患者化疗相关不良反应与健康相关生活质量之间的关系。

材料与方法

为此,对110例接受多西他赛、表柔比星和环磷酰胺治疗的乳腺癌患者开展了一项描述性横断面研究。

结果

值得强调的是,恶心、味觉障碍、周围神经病变、食欲不振、肌痛和周围水肿对生活质量有负面影响。同样,值得一提的是周围神经病变是影响更多生活质量指标的毒性反应。

结论

总之,有必要让卫生专业人员意识到化疗相关不良反应的重要性。

相似文献

1
Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer.乳腺癌患者化疗引起的不良反应与健康相关生活质量之间的关系
Medicine (Baltimore). 2020 Aug 14;99(33):e21695. doi: 10.1097/MD.0000000000021695.
2
Comparison of Doctors' and Breast Cancer Patients' Perceptions of Docetaxel, Epirubicin, and Cyclophosphamide (TEC) Toxicity.医生与乳腺癌患者对多西他赛、表柔比星和环磷酰胺(TEC)毒性认知的比较。
Breast J. 2016 May;22(3):293-302. doi: 10.1111/tbj.12571. Epub 2016 Feb 11.
3
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.紫杉烷类药物引起的周围神经病与术后接受辅助化疗的乳腺癌患者的健康相关生活质量:N-SAS BC 02,一项随机临床试验。
Support Care Cancer. 2012 Dec;20(12):3355-64. doi: 10.1007/s00520-012-1492-x. Epub 2012 May 15.
4
Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross-sectional study.接受化疗的癌症患者的味觉障碍与健康相关生活质量:一项横断面研究。
Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12633. Epub 2017 Jan 19.
5
Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).在接受辅助 TAC(多西紫杉醇、多柔比星、环磷酰胺)治疗的乳腺癌患者中生活质量和毒性与 FAC(多柔比星、环磷酰胺、5-氟尿嘧啶)相比。
Arch Gynecol Obstet. 2011 Jul;284(1):215-20. doi: 10.1007/s00404-010-1609-8. Epub 2010 Aug 26.
6
The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.年龄对接受辅助化疗的乳腺癌患者生活质量的影响:来自前瞻性多中心随机ADEBAR试验的比较分析
Clin Breast Cancer. 2017 Apr;17(2):100-106. doi: 10.1016/j.clbc.2016.10.008. Epub 2016 Oct 19.
7
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.
8
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.多西紫杉醇引起的神经病变的持续存在及其对乳腺癌幸存者生活质量的影响。
Eur J Cancer. 2015 Feb;51(3):292-300. doi: 10.1016/j.ejca.2014.11.024. Epub 2014 Dec 22.
9
Evaluation of chemotherapy-induced toxicity and health-related quality of life amongst early-stage breast cancer patients receiving Chinese herbal medicine in Malaysia.评价在马来西亚接受中草药治疗的早期乳腺癌患者的化疗毒性和与健康相关的生活质量。
Support Care Cancer. 2019 Dec;27(12):4515-4524. doi: 10.1007/s00520-019-04724-1. Epub 2019 Mar 26.
10
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen.接受辅助多西他赛、阿霉素、环磷酰胺(TAC)或5-氟尿嘧啶、阿霉素和环磷酰胺(FAC)治疗的乳腺癌患者的毒性及与健康相关的生活质量:在TAC方案中添加一级预防性粒细胞集落刺激因子的影响
Ann Oncol. 2006 Aug;17(8):1205-12. doi: 10.1093/annonc/mdl135. Epub 2006 Jun 9.

引用本文的文献

1
The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients.癌症治疗对乳腺癌患者长期心理结局和生活质量的影响。
BMC Cancer. 2025 Aug 30;25(1):1403. doi: 10.1186/s12885-025-14667-y.
2
Metformin for the treatment of breast cancer: a scoping review of randomized clinical trials.二甲双胍用于治疗乳腺癌:随机临床试验的范围综述
BMC Cancer. 2025 Aug 21;25(1):1352. doi: 10.1186/s12885-025-14468-3.
3
Social support and demoralization among patients with lung cancer in China: A moderated mediation model of self-efficacy and symptom distress.中国肺癌患者的社会支持与士气低落:自我效能感和症状困扰的调节中介模型
Asia Pac J Oncol Nurs. 2025 Jun 30;12:100749. doi: 10.1016/j.apjon.2025.100749. eCollection 2025 Dec.
4
Associations Between Chemotherapy-Induced Peripheral Neuropathy and Distress in Patients Assigned to Adjuvant Irradiation for Non-Metastatic Breast Cancer.接受非转移性乳腺癌辅助放疗患者的化疗诱导性周围神经病变与痛苦之间的关联
J Pers Med. 2025 Jun 13;15(6):248. doi: 10.3390/jpm15060248.
5
Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer.I-IIIA期乳腺癌女性患者的因素及对预定化疗方案的调整
Int J Cancer. 2025 Oct 1;157(7):1342-1353. doi: 10.1002/ijc.35494. Epub 2025 Jun 2.
6
The Genus as a Potential Source of Bioactive Compounds for Adjuvant Cancer Therapy: A Network Pharmacology Approach.作为辅助癌症治疗生物活性化合物潜在来源的属:一种网络药理学方法。
Pharmaceuticals (Basel). 2025 Apr 30;18(5):667. doi: 10.3390/ph18050667.
7
Role of a Chemo-Recovery Kit with Ayurvedic formulations - containing coral in managing chemotherapy adverse effects and maintaining quality of life in breast cancer patients.含有珊瑚的阿育吠陀配方化疗康复套件在管理乳腺癌患者化疗不良反应及维持生活质量方面的作用。
J Ayurveda Integr Med. 2025 Mar-Apr;16(2):101012. doi: 10.1016/j.jaim.2024.101012. Epub 2025 Apr 7.
8
Association of GI symptoms with health-related quality of life in cancer patients undergoing chemotherapy: a prospective study.化疗癌症患者胃肠道症状与健康相关生活质量的关联:一项前瞻性研究。
Support Care Cancer. 2025 Apr 1;33(4):336. doi: 10.1007/s00520-025-09400-1.
9
The mediating effect of positive coping in the association between inner strength and demoralization in lung cancer chemotherapy patients.积极应对方式在肺癌化疗患者内在力量与士气低落关联中的中介作用
Support Care Cancer. 2025 Feb 24;33(3):216. doi: 10.1007/s00520-025-09185-3.
10
Detection of differences in physical symptoms between depressed and undepressed patients with breast cancer: a study using K-medoids clustering.乳腺癌抑郁患者与非抑郁患者身体症状差异的检测:一项使用K-中心点聚类的研究
BMC Cancer. 2025 Jan 7;25(1):23. doi: 10.1186/s12885-024-13387-z.

本文引用的文献

1
[Chemotherapy at the end of life: Uncommon clinical practice?].[生命末期的化疗:不常见的临床实践?]
J Healthc Qual Res. 2019 Jul-Aug;34(4):201-207. doi: 10.1016/j.jhqr.2019.04.002. Epub 2019 Jun 28.
2
Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue.化疗诱导的周围神经毒性:一个多方面的、仍未解决的问题。
J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S6-S12. doi: 10.1111/jns.12337.
3
Cardiac involvement in disseminated diffuse large B-cell lymphoma, successful management with chemotherapy dose reduction guided by cardiac imaging: A case report and review of literature.心脏受累的播散性弥漫性大B细胞淋巴瘤,通过心脏成像引导下降低化疗剂量成功治疗:一例报告并文献复习
World J Clin Cases. 2019 Jan 26;7(2):191-202. doi: 10.12998/wjcc.v7.i2.191.
4
Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.预测老年人化疗毒性:比较 CARG 毒性评分与肿瘤学家基于临床判断估计毒性的预测价值。
J Geriatr Oncol. 2019 Mar;10(2):202-209. doi: 10.1016/j.jgo.2018.08.010. Epub 2018 Sep 14.
5
Adherence and safety study in patients on treatment with capecitabine.卡培他滨治疗患者的依从性与安全性研究。
Farm Hosp. 2017 Mar 1;41(2):204-221. doi: 10.7399/fh.2017.41.2.10596.
6
Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments.EQ-5D是否适用于肿瘤学?文献综述及最新进展。
Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-19. doi: 10.1586/14737167.2016.1146594. Epub 2016 Feb 18.
7
Validity and reliability of EQ-5D-3L for breast cancer patients in Korea.EQ-5D-3L在韩国乳腺癌患者中的效度和信度。
Health Qual Life Outcomes. 2015 Dec 23;13:203. doi: 10.1186/s12955-015-0399-x.
8
Health-related quality of life in women with breast cancer: a literature-based review of psychometric properties of breast cancer-specific measures.乳腺癌女性的健康相关生活质量:基于文献的乳腺癌特异性测量工具心理测量特性综述
Asian Pac J Cancer Prev. 2014;15(8):3533-6. doi: 10.7314/apjcp.2014.15.8.3533.
9
Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.运用联合分析评估乳腺癌患者对化疗副作用的偏好。
Oncologist. 2014 Feb;19(2):127-34. doi: 10.1634/theoncologist.2013-0359. Epub 2014 Jan 28.
10
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.III 期辅助试验比较三种化疗方案在可手术淋巴结阳性乳腺癌女性中的明确结果:NSABP B-38 试验。
J Clin Oncol. 2013 Sep 10;31(26):3197-204. doi: 10.1200/JCO.2012.48.1275. Epub 2013 Aug 12.